S&P 500   3,633.20 (+1.55%)
DOW   30,066.92 (+1.61%)
QQQ   293.69 (+1.14%)
AAPL   114.85 (+0.88%)
MSFT   213.57 (+1.65%)
FB   274.44 (+2.24%)
GOOGL   1,753.79 (+1.52%)
AMZN   3,128.00 (+0.96%)
TSLA   547.23 (+4.86%)
NVDA   519.35 (-1.19%)
BABA   276.93 (+2.52%)
CGC   26.81 (+8.45%)
GE   10.52 (+4.47%)
MU   63.12 (-1.65%)
AMD   84.66 (-0.76%)
T   29.30 (+2.38%)
NIO   52.73 (-4.79%)
F   9.43 (+6.43%)
ACB   8.97 (+24.93%)
NFLX   480.66 (+0.85%)
GILD   60.85 (+1.60%)
BA   220.06 (+4.03%)
DIS   151.32 (+3.66%)
S&P 500   3,633.20 (+1.55%)
DOW   30,066.92 (+1.61%)
QQQ   293.69 (+1.14%)
AAPL   114.85 (+0.88%)
MSFT   213.57 (+1.65%)
FB   274.44 (+2.24%)
GOOGL   1,753.79 (+1.52%)
AMZN   3,128.00 (+0.96%)
TSLA   547.23 (+4.86%)
NVDA   519.35 (-1.19%)
BABA   276.93 (+2.52%)
CGC   26.81 (+8.45%)
GE   10.52 (+4.47%)
MU   63.12 (-1.65%)
AMD   84.66 (-0.76%)
T   29.30 (+2.38%)
NIO   52.73 (-4.79%)
F   9.43 (+6.43%)
ACB   8.97 (+24.93%)
NFLX   480.66 (+0.85%)
GILD   60.85 (+1.60%)
BA   220.06 (+4.03%)
DIS   151.32 (+3.66%)
S&P 500   3,633.20 (+1.55%)
DOW   30,066.92 (+1.61%)
QQQ   293.69 (+1.14%)
AAPL   114.85 (+0.88%)
MSFT   213.57 (+1.65%)
FB   274.44 (+2.24%)
GOOGL   1,753.79 (+1.52%)
AMZN   3,128.00 (+0.96%)
TSLA   547.23 (+4.86%)
NVDA   519.35 (-1.19%)
BABA   276.93 (+2.52%)
CGC   26.81 (+8.45%)
GE   10.52 (+4.47%)
MU   63.12 (-1.65%)
AMD   84.66 (-0.76%)
T   29.30 (+2.38%)
NIO   52.73 (-4.79%)
F   9.43 (+6.43%)
ACB   8.97 (+24.93%)
NFLX   480.66 (+0.85%)
GILD   60.85 (+1.60%)
BA   220.06 (+4.03%)
DIS   151.32 (+3.66%)
S&P 500   3,633.20 (+1.55%)
DOW   30,066.92 (+1.61%)
QQQ   293.69 (+1.14%)
AAPL   114.85 (+0.88%)
MSFT   213.57 (+1.65%)
FB   274.44 (+2.24%)
GOOGL   1,753.79 (+1.52%)
AMZN   3,128.00 (+0.96%)
TSLA   547.23 (+4.86%)
NVDA   519.35 (-1.19%)
BABA   276.93 (+2.52%)
CGC   26.81 (+8.45%)
GE   10.52 (+4.47%)
MU   63.12 (-1.65%)
AMD   84.66 (-0.76%)
T   29.30 (+2.38%)
NIO   52.73 (-4.79%)
F   9.43 (+6.43%)
ACB   8.97 (+24.93%)
NFLX   480.66 (+0.85%)
GILD   60.85 (+1.60%)
BA   220.06 (+4.03%)
DIS   151.32 (+3.66%)
Log in
OTCMKTS:INVVY

Indivior News Headlines

$8.72
-0.08 (-0.91 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.62
Now: $8.72
$8.99
50-Day Range
$7.02
MA: $7.63
$8.80
52-Week Range
$2.23
Now: $8.72
$40.00
Volume4,836 shs
Average Volume116,716 shs
Market Capitalization$1.28 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.35

Headlines

Indivior (OTCMKTS INVVY) News Headlines Today

Source:
SourceHeadline
Opioid Use Disorder Market to Soar at 10.8% CAGR and Hit USD 4.50 Billion by 2026; Increasing Research in Opioids by Pharmaceuticals to Aid Market Expansion: Fortune Business Insights™Opioid Use Disorder Market to Soar at 10.8% CAGR and Hit USD 4.50 Billion by 2026; Increasing Research in Opioids by Pharmaceuticals to Aid Market Expansion: Fortune Business Insights™
benzinga.com - November 23 at 7:21 AM
UK EXECUTIVE CHANGE SUMMARY: New CFOs For Indivior And CostainUK EXECUTIVE CHANGE SUMMARY: New CFOs For Indivior And Costain
lse.co.uk - November 20 at 1:03 PM
Drugmaker Indivior appoints Preblick as permanent finance chiefDrugmaker Indivior appoints Preblick as permanent finance chief
reuters.com - November 20 at 1:03 PM
Indivior PLC (OTCMKTS:INVVY) Short Interest UpdateIndivior PLC (OTCMKTS:INVVY) Short Interest Update
americanbankingnews.com - November 19 at 9:34 PM
Indivior Promotes Former Shire CFO Graham Hetherington To ChairIndivior Promotes Former Shire CFO Graham Hetherington To Chair
lse.co.uk - November 19 at 8:15 AM
Indivior PLC to Post FY2020 Earnings of $0.25 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:INVVY)Indivior PLC to Post FY2020 Earnings of $0.25 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:INVVY)
americanbankingnews.com - November 18 at 6:17 AM
Indivior PLC (OTCMKTS:INVVY) Forecasted to Earn FY2023 Earnings of $0.90 Per ShareIndivior PLC (OTCMKTS:INVVY) Forecasted to Earn FY2023 Earnings of $0.90 Per Share
americanbankingnews.com - November 17 at 6:49 AM
Indivior Happy To Put Suboxone Matter Behind It As Court Approves DealIndivior Happy To Put Suboxone Matter Behind It As Court Approves Deal
lse.co.uk - November 13 at 9:22 AM
Indivior hit with $600 million in civil and criminal penalties over marketing of opioid addiction treatmentIndivior hit with $600 million in civil and criminal penalties over marketing of opioid addiction treatment
msn.com - November 12 at 6:22 PM
Indivior PLC Beat Revenue Forecasts By 11%: Heres What Analysts Are Forecasting NextIndivior PLC Beat Revenue Forecasts By 11%: Here's What Analysts Are Forecasting Next
finance.yahoo.com - November 1 at 7:41 AM
Indivior PLC (OTCMKTS:INVVY) Short Interest Down 26.3% in OctoberIndivior PLC (OTCMKTS:INVVY) Short Interest Down 26.3% in October
americanbankingnews.com - October 31 at 7:20 PM
Indivior PLC 2020 Q3 - Results - Earnings Call PresentationIndivior PLC 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - October 31 at 2:37 PM
Indivior Reinstates Annual Guidance; Quarterly Profit Falls 79%Indivior Reinstates Annual Guidance; Quarterly Profit Falls 79%
lse.co.uk - October 29 at 12:01 PM
CORRECTED-Indivior quarterly profit slumps, sets full-year revenue targetCORRECTED-Indivior quarterly profit slumps, sets full-year revenue target
reuters.com - October 29 at 12:01 PM
Indivior Says Former CEO Thaxters US Sentencing Not RelatedIndivior Says Former CEO Thaxter's US Sentencing Not Related
lse.co.uk - October 23 at 8:15 AM
Indivior Calls for Widespread Commitment to Tackling Stigma in Patients with Opioid Use DisorderIndivior Calls for Widespread Commitment to Tackling Stigma in Patients with Opioid Use Disorder
prnewswire.com - September 30 at 8:41 AM
Indivior to restructure, axe jobs as it looks to cut costsIndivior to restructure, axe jobs as it looks to cut costs
seekingalpha.com - September 24 at 12:47 PM
Indivior Reorganises Amid Challenges; Still In Line With ExpectationsIndivior Reorganises Amid Challenges; Still In Line With Expectations
lse.co.uk - September 24 at 7:47 AM
Indivior Takes Strategic Alignment ActionsIndivior Takes Strategic Alignment Actions
finance.yahoo.com - September 24 at 7:47 AM
Indivior PLC 2020 Q2 - Results - Earnings Call PresentationIndivior PLC 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 30 at 3:09 PM
Indivior second-quarter profit falls 73% as coronavirus curbs dent demandIndivior second-quarter profit falls 73% as coronavirus curbs dent demand
finance.yahoo.com - July 30 at 10:09 AM
Indivior cant reverse Suboxone antitrust class certificationIndivior can't reverse Suboxone antitrust class certification
www.reuters.com - July 29 at 8:01 AM
Indivior to pay $600 million to settle U.S. opioid treatment marketing claimsIndivior to pay $600 million to settle U.S. opioid treatment marketing claims
finance.yahoo.com - July 25 at 6:00 AM
Indivior to pay $600-million to settle U.S. opioid treatment marketing claimsIndivior to pay $600-million to settle U.S. opioid treatment marketing claims
www.theglobeandmail.com - July 24 at 5:54 PM
Indivior Finance S.ar.l. -- Moody's affirms Indivior's B3 CFR; outlook revised to stableIndivior Finance S.ar.l. -- Moody's affirms Indivior's B3 CFR; outlook revised to stable
finance.yahoo.com - July 24 at 5:54 PM
UPDATE 1-Indivior to resolve U.S. opioid treatment marketing claims for $600 millionUPDATE 1-Indivior to resolve U.S. opioid treatment marketing claims for $600 million
www.reuters.com - July 24 at 12:54 PM
Indivior to pay $600 million to resolve U.S. opioid treatment marketing claimsIndivior to pay $600 million to resolve U.S. opioid treatment marketing claims
www.reuters.com - July 24 at 12:54 PM
Indivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® FilmIndivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® Film
finance.yahoo.com - July 24 at 12:54 PM
Ex-CEO of opioid treatment maker Indivior pleads guilty in U.S.Ex-CEO of opioid treatment maker Indivior pleads guilty in U.S.
www.reuters.com - July 2 at 8:53 AM
Indivior Notes Former CEOs US DoJ Plea In "Personal Capacity"Indivior Notes Former CEO's US DoJ Plea In "Personal Capacity"
www.lse.co.uk - July 1 at 8:06 AM
Ex-CEO of opioid treatment maker Indivior pleads guilty in U.SEx-CEO of opioid treatment maker Indivior pleads guilty in U.S
www.reuters.com - June 30 at 7:29 PM
US Government Agreement With Former CEOUS Government Agreement With Former CEO
finance.yahoo.com - June 30 at 7:29 PM
Indivior Names Promotes Finance Head Crossley To CEO, Thaxter DepartsIndivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs
www.lse.co.uk - June 29 at 8:20 AM
Indiviors Sublocade shows sustained benefit in long-term observational studyIndivior's Sublocade shows sustained benefit in long-term observational study
seekingalpha.com - June 24 at 12:32 PM
New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World SettingNew Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting
finance.yahoo.com - June 24 at 12:32 PM
Indivior Chair Howard Pien Takes Medical Leave Of AbsenceIndivior Chair Howard Pien Takes Medical Leave Of Absence
www.lse.co.uk - June 15 at 10:02 AM
North America Synthetic Opioids Market to reach US$ 97.6 Billion by end of 2027 – Coherent Market InsightsNorth America Synthetic Opioids Market to reach US$ 97.6 Billion by end of 2027 – Coherent Market Insights
www.benzinga.com - May 28 at 10:20 PM
LOST MONEY IN INDIVIOR (INVVY) PLC? Class Action Lawsuit Filed to Recover Indivior Investors’ Losses, Gibbs Law GroupLOST MONEY IN INDIVIOR (INVVY) PLC? Class Action Lawsuit Filed to Recover Indivior Investors’ Losses, Gibbs Law Group
www.bloomberg.com - May 25 at 11:14 PM
Indivior PLC (INVVY) CEO Shaun Thaxter on Q1 2020 Results - Earnings Call TranscriptIndivior PLC (INVVY) CEO Shaun Thaxter on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 1:23 AM
Indivior PLC (INDV.L)Indivior PLC (INDV.L)
uk.finance.yahoo.com - May 14 at 6:11 PM
Indivior PLC ADRIndivior PLC ADR
www.barrons.com - May 14 at 6:11 PM
Indivior Q1 2020 Results Now Available; Conference Call With Leadership TodayIndivior Q1 2020 Results Now Available; Conference Call With Leadership Today
finance.yahoo.com - May 14 at 8:10 AM
Indivior profit slumps on legal costs, higher litigation provisionsIndivior profit slumps on legal costs, higher litigation provisions
finance.yahoo.com - May 14 at 8:10 AM
Reckitt Benckiser Treasury Services Plc -- Moodys assigns A3 ratings to Reckitt Benckisers new unsecured notes; outlook negativeReckitt Benckiser Treasury Services Plc -- Moody's assigns A3 ratings to Reckitt Benckiser's new unsecured notes; outlook negative
finance.yahoo.com - May 11 at 3:54 PM
BRIEF-Indivior Gets Nod For Subutex For Substitution Treatment Of Opioid Dependence In SwedenBRIEF-Indivior Gets Nod For Subutex For Substitution Treatment Of Opioid Dependence In Sweden
www.reuters.com - May 6 at 12:28 PM
Indivior withdraws 2020 forecast on coronavirus-led uncertaintyIndivior withdraws 2020 forecast on coronavirus-led uncertainty
finance.yahoo.com - April 8 at 7:07 AM
Oral Thin Film Drug Market Global Insights and Top Pharma Companies 2020Oral Thin Film Drug Market Global Insights and Top Pharma Companies 2020
www.marketwatch.com - February 14 at 7:31 AM
Indivior PLC 2019 Q4 - Results - Earnings Call PresentationIndivior PLC 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 13 at 2:47 PM
SHAREHOLDER ALERT - Indivior PLC (INVVY) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline:SHAREHOLDER ALERT - Indivior PLC (INVVY) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline:
www.bloomberg.com - February 11 at 10:08 PM
Are Insiders Buying Indivior PLC (LON:INDV) Stock?Are Insiders Buying Indivior PLC (LON:INDV) Stock?
finance.yahoo.com - February 11 at 7:06 AM
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.